erythromycin

Generic: erythromycin

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name erythromycin
Generic Name erythromycin
Labeler pd-rx pharmaceuticals, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

erythromycin 250 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 55289-075
Product ID 55289-075_4199686c-7009-b215-e063-6294a90aaa02
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA061621
Listing Expiration 2026-12-31
Marketing Start 2011-09-06

Pharmacologic Class

Established (EPC)
macrolide [epc] macrolide antimicrobial [epc]
Chemical Structure
macrolides [cs]
Physiologic Effect
decreased sebaceous gland activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55289075
Hyphenated Format 55289-075

Supplemental Identifiers

RxCUI
598006
UNII
63937KV33D
NUI
N0000009982 N0000175877 N0000175935 M0028311

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name erythromycin (source: ndc)
Generic Name erythromycin (source: ndc)
Application Number ANDA061621 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-03)
  • 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-40)
  • 56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-56)
source: ndc

Packages (3)

Ingredients (1)

erythromycin (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4199686c-7009-b215-e063-6294a90aaa02", "openfda": {"nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "unii": ["63937KV33D"], "rxcui": ["598006"], "spl_set_id": ["e54d66fa-93bb-4339-a75e-194a2e4488aa"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-03)", "package_ndc": "55289-075-03", "marketing_start_date": "20131218"}, {"sample": false, "description": "40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-40)", "package_ndc": "55289-075-40", "marketing_start_date": "20131218"}, {"sample": false, "description": "56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-56)", "package_ndc": "55289-075-56", "marketing_start_date": "20131218"}], "brand_name": "Erythromycin", "product_id": "55289-075_4199686c-7009-b215-e063-6294a90aaa02", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Macrolide Antimicrobial [EPC]", "Macrolide [EPC]", "Macrolides [CS]"], "product_ndc": "55289-075", "generic_name": "Erythromycin", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Erythromycin", "active_ingredients": [{"name": "ERYTHROMYCIN", "strength": "250 mg/1"}], "application_number": "ANDA061621", "marketing_category": "ANDA", "marketing_start_date": "20110906", "listing_expiration_date": "20261231"}